15 completed, 5 recruiting, 1 terminated. 16 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 16 | Completed 11, Recruiting 4, Terminated 1 |
Follow Echosens: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP) FibroScan, Right-sided Heart Catheterization, Transthoracic echocardiography - Heart Failure, Heart Failure - NYHA II - IV | Not applicable | Recruiting | Echosens | 149 | 2026-04-23 | 2026-09-23 |
| Evaluation of Fibroscan® Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department FibroScan® - Acute Heart Failure (AHF) | Not applicable | Recruiting | Assistance Publique - Hôpitaux de Paris | 100 | 2026-04-02 | 2026-10-27 |
| Development of a FibroScan Liver Examination Using a Single Probe Research FibroScan - Liver Diseases | Not applicable | Recruiting | Echosens | 389 | 2025-11-14 | 2026-08-05 |
| FibroScan-Reproducibility and Repeatability Study FibroScan, Liver Enzymes - Non-Alcoholic Fatty Liver Disease, Liver Disease; Alcohol-Related | Not applicable | Completed | Echosens | 108 | 2025-07-16 | 2026-04-13 |
| Development of a New Method for Liver Stiffness Measurement Using FibroScan Research FibroScan (FS) - Liver Diseases | Not applicable | Recruiting | Echosens | 153 | 2024-11-08 | 2026-08-05 |
| Global Research Initiative for Patients Screening on MASH MASH, MASLD | Recruiting | Julius Clinical | 10000 | 2023-06-30 | 2024-08-01 | |
| Validation of the New Vibration-guided FibroScan Examination Research FibroScan (FS) - Liver Diseases | Not applicable | Completed | Echosens | 270 | 2022-10-26 | 2025-01-15 |
| Optimization of Spleen VCTE Examinations with FibroScan FibroScan examination (S), FibroScan examination (M), FibroScan examination (XL) - Spleen; Fibrosis | Not applicable | Terminated | Echosens | 433 | 2022-06-01 | 2025-01-15 |
| The Visceral Adiposity Measurement and Observation Study Diagnostic Test, HIV Anti-retroviral Background Therapy - HIV, HIV-Infections | Completed | Theratechnologies | 196 | 2022-04-18 | 2023-11-18 | |
| Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE Examination Research FibroScan - Liver Fibrosis | Not applicable | Completed | Echosens | 200 | 2021-04-06 | 2021-10-13 |
| Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Assessment of Spleen Stiffness Using VCTE by FibroScan. VCTE with splenic stiffness measurement - Advanced Chronic Liver Disease, NASH | Completed | Indiana University | 298 | 2020-12-01 | 2024-04-19 | |
| Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as Reference FibroScan 530 Compact - Chronic Liver Disease | Not applicable | Completed | Echosens | 207 | 2019-09-24 | 2022-08-08 |
| Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients For the first 60 patients: 3 XXL probe prototypes of the FibroScan 630 Research Model, From patient 61 to patient 120: 1 XXL probe prototype of the FibroScan 630 Research Model - Obesity, Morbid, Liver Fibrosis | Not applicable | Completed | Echosens | 180 | 2019-09-19 | 2022-08-08 |
| Transient Elastography DEdicated to Cosmetology And Dermatology (TEDECAD) Cutometer, High resolution ultrasonography (echography), Elastography - Venous Insufficiency, Lymphedema | Not applicable | Completed | University Hospital, Tours | 130 | 2014-04-01 | 2025-12-26 |
| Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference. FibroScan® examination. - Non-alcoholic Fatty Liver Disease | Not applicable | Completed | Echosens | 450 | 2014-01-01 | 2017-07-27 |
| Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis Fibroscan, Blood test for biological assessment of liver function, MRI - Liver Steatosis | Not applicable | Completed | University Hospital, Tours | 72 | 2013-04-01 | 2026-06-15 |
| Evaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric Surgery Evaluation of the Diagnostic of Hepatic Fibrosis With the XL Probe of the Fibroscan Versus Biopsies in Severe Obese Patients Candidates to Bariatric Surgery - Steatosis, Obesity | Completed | European Georges Pompidou Hospital | 132 | 2012-04-04 | 2018-06-07 | |
| Spleen Stiffness Measurement With FibroScan Fibroscan® examination - Cirrhosis | Not applicable | Completed | Echosens | 403 | 2012-03-01 | 2018-10-10 |
| Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients FibroScan M and XL probes - Liver Fibrosis, Cirrhosis | Not applicable | Completed | Echosens | 300 | 2009-07-01 | 2010-11-16 |
| FIBROSCAN Validation and Interest of Fibrotest - FIBROSCAN Association for Fibrosis Diagnosis in Alcoholic Liver Disease Alcoholic Liver Disease | Completed | Assistance Publique - Hôpitaux de Paris | 227 | 2008-09-01 | 2014-01-23 |
Showing 20 of 21. Sign in to see all of them.
Liver Cirrhosis (7) · Fibrosis (5) · Liver Diseases (5) · Fatty Liver (4) · Non-alcoholic Fatty Liver Disease (4) · Obesity (2) · Acquired Immunodeficiency Syndrome (1) · Diabetes Mellitus, Type 2 (1) · Emergencies (1) · Esophageal and Gastric Varices (1) · HIV Infections (1) · HIV-Associated Lipodystrophy Syndrome (1) · Heart Failure (1) · Hepatitis B (1) · Hepatitis C (1)
Hematologic Tests (2) · Diagnostic Tests, Routine (1) · Elasticity Imaging Techniques (1) · Tomography, X-Ray Computed (1) · Ultrasonography (1) · Urination (1)
France (13) · United States (4) · Romania (3) · United Kingdom (3) · Germany (2) · Italy (2) · Netherlands (2) · Spain (2) · Belgium (1) · Canada (1) · Czechia (1) · Greece (1) · Hong Kong (1) · Poland (1) · Portugal (1)
Diederick E. Grobbee, MD/PhD/FESC (1) · Jeffery Carr, DR (1) · John Koethe, MD (1) · Jordan Lake, MD (1) · Manuel Castro Cabezas, MD/PhD (1) · Nezam H Afdhal, M.D. (1) · Oscar H. Franco, MD/PhD/FESC/FFPH (1)
PMID 25528010, PMID 30689971, PMID 31444849, PMID 32027858, PMID 32187631, PMID 32359748, PMID 39809636, PMID 40447415